Hair Million promotes hair growth in both women and men. It is made of healthy and safe herbs that have been well documented and in use for thousands of years, especially in Asia. Although these herbs have not yet been scientifically proven by placebo-controlled clinical trials nor the ingedients of the herbs charaterized in laboratory, the herbal formula has been proven efficacious anecdotally in a number of people who experience hair thinning and hair loss. There are other herbs and nutritions that also work in anecdotal cases. For instance, Saw palmetto fruit extract have beens shown effective. Other herbs, such as sage, evening primrose, horse chestnut, horsetail, rosemary have been suggested. B vitamins, especially biotin might help as well.

Hair Million is a finest product that would ward off hair loss and promote hair growth, without side effect. Hair Million should be orally taken as suggested for a few months to see the positive effects: stopping hair thinning, and hair loss, and observing new hair growth. For some individuals, none of the hair growth products or methods would work, and the reasons are not always clear. People with alopecia areata would certainly benefit from Hair Million. Once you know it works for you, you could take it for months and years. It often results in complete restoration of hair.



  • Vitamin D3 analogs stimulate hair growth in nude mice.
  • Cosmetics and hair loss.
  • Treatment of hyperandrogenic alopecia in women.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Vitamin D3 analogs stimulate hair growth in nude mice.
  • Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
  • Female pattern hair loss.
  • An endocrinopathy characterized by dysfunction of the pituitary-adrenal axis and alopecia universalis: supporting the entity of a triple H syndrome.
  • Female pattern hair loss.
  • Treatment of hyperandrogenic alopecia in women.
  • The hydraulic influence in androgen-related hair growth: implications in autoimmune disease.
  • TrichoScan. A new instrument for digital hair analysis
  • Disappearance of pili annulati following an episode of alopecia areata.
  • Hair Transplantation for Men with Advanced Degrees of Hair Loss
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Treatment of hyperandrogenic alopecia in women.
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Does the recipient site influence the hair growth characteristics in hair transplantation?
  • Hair Transplantation for Men with Advanced Degrees of Hair Loss
  • Treatment of hyperandrogenic alopecia in women.
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • The art of repair in surgical hair restoration part I: basic repair strategies.
  • Epidemiology and genetics of alopecia areata.
  • Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
  • 'Cyclic alopecia' in Msx2 mutants: defects in hair cycling and hair shaft differentiation.
  • The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • Hair loss in women with hyperandrogenism: four cases responding to finasteride.
  • Female pattern hair loss.
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
  • Hair loss in women with hyperandrogenism: four cases responding to finasteride.
  • Treatment of hyperandrogenic alopecia in women.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • The art of repair in surgical hair restoration--part II: the tactics of repair.
  • Androgenetic alopecia in the man
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Androgenetic alopecia
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • The hair follicle as a target for gene therapy
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Disappearance of pili annulati following an episode of alopecia areata.
  • Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Baldness: Does appearance matter?
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience.
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • The hair follicle as a target for gene therapy
  • Mouse models for human hair loss disorders.
  • The hydraulic influence in androgen-related hair growth: implications in autoimmune disease.
  • Androgens and alopecia.
  • Female pattern hair loss.
  • Assessment of hair loss: clinical relevance of hair growth evaluation methods.
  • There is no clear association between low serum ferritin and chronic diffuse telogen hair loss.
  • The hydraulic influence in androgen-related hair growth: implications in autoimmune disease.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • Androgenetic alopecia
  • Baldness: Does appearance matter?
  • Approach to the adult female patient with diffuse nonscarring alopecia.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Epidemiology and genetics of alopecia areata.
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • Postmenopausal frontal fibrosing alopecia.
  • Steroid sulfatase in the human hair follicle concentrates in the dermal papilla.
  • A philosophy and strategy for surgical hair restoration: a 10-year experience.
  • Baldness: Does appearance matter?
  • Postmenopausal frontal fibrosing alopecia.



    Hair loss and hair growth online references:

    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |